top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances in the Treatment of Renal Cell Carcinoma
Advances in the Treatment of Renal Cell Carcinoma
Autore Reynolds Paul
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (221 p.)
Soggetto topico Medicine
Soggetto non controllato artesunate (ART)
autophagy
biomarker
biomarkers
ccRCC
chloroquine
clear cell renal cell carcinoma
cysteine cathepsin inhibitors
cysteine cathepsins
evolution
evolutionary trajectory
ferroptosis
genomic signature
growth inhibition
hydroxychloroquine
immune checkpoint inhibitors
immune-based combination therapies
immunotherapy
individualization
kidney cancer
lysosome
metastatic
metastatic renal cell carcinoma
mRCC
network meta-analysis
PD-L1
predictive
RCC
reactive oxygen species (ROS)
renal cancer
renal cell cancer
renal cell carcinoma
renal cell carcinoma (RCC)
ROC-325
second line therapy
soluble factors
sunitib resistance
TKIs
Traditional Chinese Medicine (TCM)
transcriptomic analysis
treatment
tyrosine kinase inhibitors
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557615503321
Reynolds Paul  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Biomarker Research and Personalized Medicine
Cancer Biomarker Research and Personalized Medicine
Autore Meehan James
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (428 p.)
Soggetto topico Medicine and Nursing
Oncology
Soggetto non controllato 1H-NMR
Akt/mTOR
AmpliSeq
anastomotic leak
autophagy
bioinformatics
biomarker
biomarkers
bladder tumor
breast cancer
cancer biomarkers
cancer vaccine
chemoradiotherapy
chemoresistance
chemotherapy
circulating tumor cells
clear cell renal cell carcinoma
colorectal cancer
comparative oncology
CREB1
cytokine signalling
DNA methylation
drug perturbation
epigenetics
exosomes
FOXO3
gastric cancer
GBP5
glycopeptide
gp130
haptoglobin
head and neck cancer
head and neck squamous cell carcinoma
hepatocellular carcinoma
HNSCC
hormone-dependent carcinogenesis
HPV genotyping
IL13Rα2
IL6ST
immune response
intestinal anastomosis
JAK2
LC-MS/MS
lincRNA-p21
lipidomics
lipoprotein lipase
lipoprotein subfractions
liquid biopsy
liquid-based biomarkers
localized prostate cancer
long non-coding RNA
lymph node metastasis
lymphocyte-to-monocyte ratio
mass spectrometry
meta-analysis
microRNA
middle-up-down
multiphasic multidetector computed tomography
n/a
One Health
ovarian cancer
p16 expression
p53
peripheral blood parameters
personalized medicine
precision medicine
predictive biomarker
predictive tools
prognostic factors
prognostic tools
prostate cancer
radiomics
radioresistance
radiosensitivity biomarkers
radiotherapy
rectal cancer
renal cell carcinoma
saliva
secretome
taxane
telmisartan
tissue-based biomarkers
translational research
transurethral resection
triple-negative breast cancer
tumor recurrence
WHO/ISUP nuclear grade
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910674370003321
Meehan James  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Metastatic Progression and Tumour Heterogeneity
Metastatic Progression and Tumour Heterogeneity
Autore Hollande Fred
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (312 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato 3D cultures
acidosis
ADH
angiocrine factor
beta-catenin paradox
biomechanics
breast cancer
carbonic anhydrase
cell fate
cellular heterogeneity
circulating tumor cells
circulating tumor cells (CTCs)
clear cell renal cell carcinoma
clonality
collective and single-cell migration
colon cancer
colorectal cancer
CTC-clusters
DCIS
deficient mismatch repair
EMT
endometrial carcinoma
epigenetics
epithelial mesenchymal plasticity
epithelial-to-mesenchymal transition
esophageal squamous cell carcinoma
extracellular vesicles
gene expression
genomics
heterogeneity
hybrid E/M
hyperpolarized 13C MRI
immune checkpoints
immune microenvironment
immunotherapy
interstitial pH
intra-tumour heterogeneity
intratumor heterogeneity
lactic acid
magnetic resonance imaging
mammary gland
metaplastic carcinoma
metastasis
metastatic niche
microsatellite instability
miRNA expression
multisite tumor sampling
mutation
natural killer cells
nuclear medicine
organoids
pancreatic cancer
PET
phenotypic plasticity
PI3K/AKT pathway
plasticity
positron emission tomography
precision medicine
radiomics
radiopharmaceuticals
review
signaling
single-cell analysis
single-cell RNAseq
subclonal diversity
SUV
target discovery
targeted therapy
TP53
treatment resistance
tumor ecology
tumor endothelial cell
tumor evolution
tumor heterogeneity
tumor microenvironment
tumor mutation burden
uterine carcinosarcoma
Wnt signaling
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557105803321
Hollande Fred  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Pleiotropic Action of Selenium in the Prevention and Treatment of Cancer, and Related Diseases
Pleiotropic Action of Selenium in the Prevention and Treatment of Cancer, and Related Diseases
Autore Rustum Youcef M
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 online resource (166 p.)
Soggetto topico Biology, life sciences
Soggetto non controllato anticancer
anticancer agent
antitumor activity
apoptosis
cancer
cancer stem cells
cell plasticity
chemotherapeutics
clear cell renal cell carcinoma
clear-cell renal cell carcinoma microRNAs
disease
DNA damage
DNA damage and repair
EMT
entosis
epigenetics
ER stress
glutathione
head and neck cancer
HIF
hSP56
hypoxia
hypoxia-inducible factor
hypoxia-inducible factors (HIFs)
immune evasion
isoselenourea
lipid peroxidation
malignant
melanoma
methylseleninic acid
methylselenocysteine
methylselenoesters
miRNA
mTOR inhibitors
PD-L1
radiation
SBP1
Se-containing nanoparticles
SELENBP1
selenium
selenium species
selenium-binding protein 1
seleno-l-methionine
STAT3
tocopherol
tumor heterogeneity
tumor microenvironment
VEGF
viability
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910346851003321
Rustum Youcef M  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Renal Cell Carcinoma
Renal Cell Carcinoma
Autore López José I
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (500 p.)
Soggetto topico Biology, life sciences
Soggetto non controllato 11) translocation renal cell carcinoma
ALK
AMP-activated protein kinases
anaplastic lymphoma kinase rearrangement
aurora A
biomarker
cancer immunotherapy
cancer-specific survival
CDKN1A expression
checkpoint inhibitors
chromophobe renal cell carcinoma
chromosomal loss
chronic kidney disease
circular RNAs in a clinico-genomic predictive model
clear cell renal cell carcinoma
clear cell Renal Cell Carcinoma
collecting duct carcinoma
copy number alteration
copy number analysis
copy number loss
curcumin
cytoreductive nephrectomy
diagnostic and prognostic markers
drug sensitivity
efficacy
emerging entity
EMT like
eosinophilic variant
ESC
everolimus
EVI1
experimental validation of circular RNA
FISH
FOXO3
gene expression
gene signature
genetic association
ghrelin
glutathione metabolism
glutathione transferase omega 1
glutathione transferase omega 2
glycomarkers
glycoproteomics
HOT
hyperosmolality
identification of circular RNAs
IL-1?
IL-2
IL13R?1
IL4R?
immune checkpoint inhibitors
immune infiltration
immunohistochemistry
immunotherapy
inflammation markers
integrins
intratumour heterogeneity
invasion
JAK2
kidney
kidney cancer
label-free
LOT
metabolic reprogramming
metabolome
metabolome profiling
metastasis
metastatic ccRCC
microRNA
miR-133b
miR-146a-5p
miR-155-5p
MiT family translocation renal cell carcinoma
MMP-9
MMP10
molecular genetic features
MTA2
mTOR
mTOR inhibitors
mutation
N-glycomapping
n/a
nephrectomy
new entity
NK cells
oncocytic renal tumor
overall survival
pale cell
Papillary renal cell carcinoma (pRCC)
patient survival
PBRM1
PD-L1
pentose phosphate pathway
PI3K/Akt/mTOR
polybromo-1
polymorphism
PPP
practical approach
predictive factors
predictive role
pro-IL-1?
prognosis
prognostic factors
programmed death-ligand 1
proliferation
proteome profiling
Raf/MEK/ERK
RCC
recurrence free survival
recurrence-free survival
renal cancer
renal cell
renal cell cancer
renal cell carcinoma
review
RNA sequencing
sarcomatoid
SMAD proteins
solute carrier proteins
statins
survival
survival prediction
t(6
targeted therapy
TCA cycle
TCGA
TFE3
TFEB
TFEB-amplified renal cell carcinoma
toxicity
transforming growth factor beta
tumor adhesion
tumor microenvironment
tumor migration
tumor slice culture
tyrosine kinase inhibitors
unclassified renal cell carcinoma
unclassified renal tumor
uric acid
urine
VEGF inhibitors
von Hippel-Lindau
Xp11 translocation renal cell carcinoma
ISBN 3-03928-639-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910404087003321
López José I  
MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui